Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) (PAR-22-089)

GRANT Friday, February 25, 2022- 15:15 National Institute of Neurological Disorders and Stroke, National Institute on Aging Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-22-089.html

Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) (RFA-AG-23-007)

GRANT Friday, February 25, 2022- 15:15 National Institute on Aging NIA intends to commit $1,280,000 in FY 2023 to fund 1 award. Future year awards will depend on NIA appropriations, but NIA also intends to commit $1,760,000 in FY 2024; $2,048,000 in FY 2025; $2

Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) (RFA-AG-23-012)

GRANT Friday, February 25, 2022- 15:15 National Institute on Aging NIA intends to commit $2.5 million in FY 2023 to fund 5-6 awards. October 11, 2022. All applications are due by 5:00 PM local time of applicant organization. https://grants.nih.gov/grants/guide/

Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) (RFA-AG-23-013)

GRANT Friday, February 25, 2022- 15:15 National Institute on Aging NIA intends to commit $2.4 million in FY 2023 to fund 4-5 awards. October 11, 2022. All applications are due by 5:00 PM local time of applicant organization. https://grants.nih.gov/grants/guide/

Notice of Special Interest (NOSI): Postmortem Pathology, Cellular, and Molecular Analyses to Determine the Significance of White Matter Lesions and other Imaging Findings of Presumed Vascular Origin During Life (NOT-NS-22-001)

GRANT Friday, February 18, 2022- 15:30 National Institute of Neurological Disorders and Stroke National Institute on Aging Administrative supplement April 1, 2022, by 5:00 PM local time of the applicant organization. https://grants.nih.gov/grants/guide/notice-f

Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) (RFA-AG-23-005)

GRANT Friday, February 18, 2022- 15:30 National Institute on Aging For the R61 planning phase, the budget for direct costs may not exceed $200,000. For the R33 implementation phase, the budget for direct costs may not exceed $400,000 in any single year. July 01

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) (RFA-NS-22-026)

GRANT Friday, February 11, 2022- 15:15 National Institutes of Health Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed) (RFA-NS-22-027)

GRANT Friday, February 11, 2022- 15:15 National Institutes of Health Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-027.html

Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed) (RFA-NS-22-035)

GRANT Friday, February 11, 2022- 15:15 National Institutes of Health NINDS intends to commit approximately $800,000- $1,000,000 in FY 2023 to fund up to 5 awards. April 19, 2022; all applications are due by 5:00 PM local time of applicant organization. https://

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) (PAR-22-100)

GRANT Friday, February 4, 2022- 15:45 National Center for Advancing Translational Sciences Multiple due dates, see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-22-100.html

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) (PAR-22-101)

GRANT Friday, February 4, 2022- 15:45 National Center for Advancing Translational Sciences Multiple dates, see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-22-101.html

NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed) (PAR-22-110)

GRANT Friday, February 4, 2022- 15:45 National Institute on Aging Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-22-110.html

Investigator-Initiated, Translational, and Advancing Diagnostics Research Awards

GRANT Monday, January 31, 2022- 11:45 Peer-Reviewed Alzheimer's Research Program, CDMRP, Department of Defense $750,000- $2.5 million https://cdmrp.army.mil/pubs/press/2022/22prarppreann

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) (PAR-22-078)

GRANT Friday, January 28, 2022- 16:00 National Institutes of Health The Lasker Clinical Research Scholars Program supports research activities during the early stage careers of independent clinical researchers. The program contains two phases: In the first phas

BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional) (RFA-MH-22-115)

GRANT Friday, January 28, 2022- 16:00 National Institutes of Health NIH intends to commit an estimated total of $10,000,000 to fund 6-9 awards. Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-115.html